EP1581635A4 - Mise au silence de genes a mediation par sirna - Google Patents

Mise au silence de genes a mediation par sirna

Info

Publication number
EP1581635A4
EP1581635A4 EP03814141A EP03814141A EP1581635A4 EP 1581635 A4 EP1581635 A4 EP 1581635A4 EP 03814141 A EP03814141 A EP 03814141A EP 03814141 A EP03814141 A EP 03814141A EP 1581635 A4 EP1581635 A4 EP 1581635A4
Authority
EP
European Patent Office
Prior art keywords
sirna
genes
silencing
media
silencing media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03814141A
Other languages
German (de)
English (en)
Other versions
EP1581635A2 (fr
Inventor
Henry Paulson
Victor Miller
Cynthia Gouvion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation
Original Assignee
University of Iowa Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/430,351 external-priority patent/US20040023390A1/en
Priority claimed from PCT/US2003/016887 external-priority patent/WO2004013280A2/fr
Application filed by University of Iowa Research Foundation filed Critical University of Iowa Research Foundation
Publication of EP1581635A2 publication Critical patent/EP1581635A2/fr
Publication of EP1581635A4 publication Critical patent/EP1581635A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031—Beta-glucuronidase (3.2.1.31)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des molécules ARN à faible degré d'interférence (sIRNA) ciblées contre un allèle d'intérêt et des procédés utilisant ces molécules sIRNA.
EP03814141A 2002-12-17 2003-12-16 Mise au silence de genes a mediation par sirna Withdrawn EP1581635A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US430351 1982-09-29
US32208602A 2002-12-17 2002-12-17
US322086 2002-12-17
US10/430,351 US20040023390A1 (en) 2002-08-05 2003-05-05 SiRNA-mediated gene silencing with viral vectors
PCT/US2003/016887 WO2004013280A2 (fr) 2002-08-05 2003-05-26 Silençage genique a mediation par arnsi specifique des alleles
WOPCT/US03/16887 2003-05-26
PCT/US2003/040292 WO2004058940A2 (fr) 2002-08-05 2003-12-16 Mise au silence de genes a mediation par sirna

Publications (2)

Publication Number Publication Date
EP1581635A2 EP1581635A2 (fr) 2005-10-05
EP1581635A4 true EP1581635A4 (fr) 2007-10-17

Family

ID=32685878

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03814141A Withdrawn EP1581635A4 (fr) 2002-12-17 2003-12-16 Mise au silence de genes a mediation par sirna

Country Status (2)

Country Link
EP (1) EP1581635A4 (fr)
AU (1) AU2003301030A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013355A1 (fr) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation Silençage genique a mediation par arnsi a l'aide de vecteurs viraux
WO2004013280A2 (fr) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation Silençage genique a mediation par arnsi specifique des alleles
WO2004047872A2 (fr) * 2002-11-26 2004-06-10 Medtronic, Inc. Traitement de maladie neurodegenerative par administration intracranienne d'arnsi

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013355A1 (fr) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation Silençage genique a mediation par arnsi a l'aide de vecteurs viraux
WO2004013280A2 (fr) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation Silençage genique a mediation par arnsi specifique des alleles
WO2004047872A2 (fr) * 2002-11-26 2004-06-10 Medtronic, Inc. Traitement de maladie neurodegenerative par administration intracranienne d'arnsi

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRUMMELKAMP T R ET AL: "STABLE SUPPRESSION OF TUMORIGENICITY BY VIRUS-MEDIATED RNA INTERFERENCE", CANCER CELL, XX, US, vol. 2, no. 3, September 2002 (2002-09-01), pages 243 - 247, XP009006464, ISSN: 1535-6108 *
DING H ET AL: "Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis", AGING CELL, BLACKWELL PUBLISHING,, GB, vol. 2, 2003, pages 209 - 217, XP002389534, ISSN: 1474-9718 *
DONZE O ET AL: "RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 30, no. 10, 15 May 2002 (2002-05-15), pages e46 - 1, XP002279045, ISSN: 0305-1048 *
MILLER V M ET AL: "Allele-specific silencing of dominant disease genes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 100, no. 12, 10 June 2003 (2003-06-10), pages 7195 - 7200, XP002278730, ISSN: 0027-8424 *
MILLER V M ET AL: "Targeting Alzheimer's disease genes with RNA interference: An efficient strategy for silencing mutant alleles", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 32, no. 2, 2004, pages 661 - 668, XP002315762, ISSN: 0305-1048 *
SCHWARZ D.S. ET AL: "Asymmetry in the assembly of the RNAi enzyme complex", CELL, vol. 115, 17 October 2003 (2003-10-17), pages 199 - 208, XP002521543, DOI: 10.1016/S0092-8674(03)00759-1 *

Also Published As

Publication number Publication date
EP1581635A2 (fr) 2005-10-05
AU2003301030A1 (en) 2004-07-22
AU2003301030A8 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
WO2004058940A3 (fr) Mise au silence de genes a mediation par sirna
WO2006083800A3 (fr) Silençage nucleique de gene de maladie d'huntington
WO2004045543A3 (fr) Arnsi fonctionnel et hyperfonctionnel
WO2006006948A3 (fr) Methodes et compositions permettant de selectionner des arnsi presentant une fonctionnalite amelioree
WO2007048046A3 (fr) Extinction par arnsi de l'expression du gene de filovirus
WO2006085987A3 (fr) Arn interference dans des cellules epitheliales respiratoires
WO2004061081A3 (fr) Synthetic sirna compounds and methods for the downregulation of gene expression
WO2004065613A3 (fr) Constructions geniques permettant l'expression inductible de petites molecules d'arn pour une extinction genique ciblee
NO20082783L (no) Induserbare ekspresjonssystemer
DE60207601D1 (de) Methode für die in vitro synthese von kurzen dobbelsträngigen rnas
WO2008150897A3 (fr) Réduction de la toxicité de l'interférence arn hors cible
ATE439440T1 (de) Sirna-vermitteltes gen-silencing von alpha- synuklein
AU2009236219A8 (en) Silencing of CSN5 gene expression using interfering RNA
EP1442143A4 (fr) Inhibition de l'expression du gene bcl2 induite par interference arn au moyen de petits acides nucleiques interferents (sina)
EP1750771A4 (fr) Micro-arn d'ilot pancreatique et methodes permettant d'inhiber ce dernier
WO2007135685A3 (fr) Compositions d'inactivation de l'expression de la gibbérelline-2-oxydase et leurs utilisations
ATE335852T1 (de) Happier mapping
WO2003057840A3 (fr) Compositions pour silençage genique regule par adn
WO2005042705A3 (fr) Composes de petits arn interferents et de micro-arn, et procede pour les concevoir, les produire et les utiliser
WO2006013072A3 (fr) Procede pour l'isolement de sequences de terminaison de transcription
WO2007014077A3 (fr) Modulation de l'arni du gene rho-a et utilisations de celle-ci
DK1316614T3 (da) Kontinuerlig fremgangsmåde til modifikation af stivelse og stivelsederivater ved hjælp af forgreningsenzymer
WO2006045591A3 (fr) Procede et produits de synthese permettant d'administrer un arn en double brin a des organismes de parasites
EP2325314A3 (fr) Ciblage d'intermédiaires de réplication de brins opposés de virus monocaténaire par ARNi
ATE428783T1 (de) Expressionssystem für sirna

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050715

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 21/04 20060101ALI20060530BHEP

Ipc: C07H 21/02 20060101ALI20060530BHEP

Ipc: A01N 47/40 20060101ALI20060530BHEP

Ipc: C12N 15/63 20060101ALI20060530BHEP

Ipc: C12N 15/00 20060101ALI20060530BHEP

Ipc: C12P 19/34 20060101ALI20060530BHEP

Ipc: C12Q 1/68 20060101AFI20060530BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20070914

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 48/00 20060101ALI20070910BHEP

Ipc: A61K 38/00 20060101ALI20070910BHEP

Ipc: C07H 21/04 20060101ALI20070910BHEP

Ipc: C12N 15/11 20060101AFI20070910BHEP

17Q First examination report despatched

Effective date: 20080310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090906